AM
Aqua Medical
United States · Healthtech
Aqua Medical develops endoscopic devices and an investigational procedure intended to improve metabolic control in people with Type 2 diabetes.
Product
Its PIMA procedure uses radiofrequency-generated vapor to treat targeted tissue in the proximal small intestine through a standard endoscope. The company is evaluating the approach through clinical studies.
Aqua is based in Pleasanton, California. Its underlying ablation platform has gastrointestinal clearance, while the Type 2 diabetes application remains investigational.
Funding history
1 round · 0 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series B | Undisclosed | Relevance Ventures — Lead |